Accuray Sets Terms

Accuray Inc., a Sunnyvale, Calif.-based developer of a robotic radio-surgery system, has set its proposed IPO terms to 13.33 million common shares being offered at between $14 and $16 per share. It plans to trade on the Nasdaq under ticker symbol ARAY, with JPMorgan and UBS serving as co-lead underwriters. Shareholders include BVI International Investment and Maubeni Corp. www.accuray.com